Wir sind mit live! Mehr erfahren

Plexus

PLXS

Börsenwert 6,14 Mrd. $

230,47 USD

-8,24

3,45 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

Vor Börsenbeginn

Nachbörslich

230,47

0,00

0 %

1 Tag

-3,45 %

5 Tage

-11,43 %

1 Monat

-4,89 %

3 Monate

-7,37 %

6 Monate

3,41 %

Seit Jahresbeginn

51,4 %

1 Jahr

53,32 %

5 Jahre

149,75 %

10 Jahre

404,53 %

Profil: Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.

Mitarbeiter: 20.000

Technologie Elektronische Komponenten

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 62,5 %

Neutral 37,5 %

Negativ 0 %

Plexus Sets Fiscal Fourth Quarter and Fiscal Year 2026 Earnings Release Date

NEENAH, WI, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) announced today it will release its fiscal fourth quarter and fiscal year 2026 results after market close on Wednesday, October 28, 2026. Plexus' management will host a conference call to discuss its fiscal fourth quarter and fiscal year 2026 results on Thursday, October 29, 2026 at 8:30 a.m. Eastern Time. An audio webcast of the call and accompanying slides will be available in the investor relations section of the company website, plexus.com.

Plexus Sets Fiscal Fourth Quarter and Fiscal Year 2026 Earnings Release Date

Zacks Investment Research

Plexus (PLXS) is a Great Momentum Stock: Should You Buy?

Does Plexus (PLXS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Plexus (PLXS) is a Great Momentum Stock: Should You Buy?

Zacks Investment Research

Plexus (PLXS) Up 1.4% Since Last Earnings Report: Can It Continue?

Plexus (PLXS) reported earnings 30 days ago. What's next for the stock?

Plexus (PLXS) Up 1.4% Since Last Earnings Report: Can It Continue?

Zacks Investment Research

Can Plexus (PLXS) Climb 25.22% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in Plexus (PLXS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Can Plexus (PLXS) Climb 25.22% to Reach the Level Wall Street Analysts Expect?

Zacks Investment Research

Buy 3 Momentum Anomaly Stocks as Surging Oil Prices Rattle Markets

Oil-price volatility is shaking markets, but Plexus, Twilio and MACOM stand out as momentum stocks with strong one-year gains and recent pullbacks.

Buy 3 Momentum Anomaly Stocks as Surging Oil Prices Rattle Markets

Zacks Investment Research

Earnings Estimates Rising for Plexus (PLXS): Will It Gain?

Plexus (PLXS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Earnings Estimates Rising for Plexus (PLXS): Will It Gain?

Zacks Investment Research

Plexus (PLXS) Is Up 7.56% in One Week: What You Should Know

Does Plexus (PLXS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Plexus (PLXS) Is Up 7.56% in One Week: What You Should Know

Zacks Investment Research

These 4 Electronics-Manufacturing Stocks Are Surging, and It's Still Time to Buy

Electronics manufacturing services (EMS) providers are benefiting from a powerful combination of secular technology investment, rising product complexity, and increased outsourcing by original equipment manufacturers (OEMs).

These 4 Electronics-Manufacturing Stocks Are Surging, and It's Still Time to Buy

Zacks Investment Research

Should Investors Buy PLXS as Growth Accelerates but Cash Flow Weakens?

Plexus is delivering faster growth, higher earnings and wider margins, but premium valuation and weaker near-term cash flow temper the buy case.

Should Investors Buy PLXS as Growth Accelerates but Cash Flow Weakens?

Zacks Investment Research

Plexus Q3 Beat, Strong Outlook Clouded by Free Cash Flow Concerns

PLXS' broad Q3 beat and stronger growth outlook extend its runway, but rising working-capital needs put free cash flow conversion under scrutiny.

Plexus Q3 Beat, Strong Outlook Clouded by Free Cash Flow Concerns

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt